Biden administration launches national research plan to understand and treat long Covid

Biden administration launches national research plan to understand and treat long Covid


U.S. President Joe Biden delivers remarks on the coronavirus disease (COVID-19) before receiving a second COVID-19 booster vaccination in the Eisenhower Executive Office Building’s South Court Auditorium at the White House in Washington, U.S., March 30, 2022.

Kevin Lamarque | Reuters

President Joe Biden on Tuesday directed the Health and Human Services Department to lead a federal effort to research the diagnosis and treatment of long Covid.

The national research plan will accelerate enrollment of 40,000 people in the National Institutes of Health’s study of the long-term effects of Covid-19 infection, according to the White House. The NIH launched the large study, known as Recover, in September.

The federal effort will also tap a nationwide survey from the Department of Veterans Affairs about persistent symptoms after Covid infection, and a Defense Department study on the risk factors for developing the disease among service members.

HHS Secretary Xavier Becerra and the White House Covid response team will discuss the initiative during a press briefing at 3 p.m. ET.

Some people who contract Covid experience symptoms months later. These symptoms, which are debilitating for some, include difficulty breathing, fatigue, problems concentrating, body aches, tingling sensations and mood changes, among others.

Even people who only had a mild illness after infection and individuals who initially had no symptoms can develop long Covid, according to the Centers for Disease Control and Prevention.

Other individuals also experience autoimmune conditions that can affect multiple organ systems including heart, lung, kidney, skin and brain functions. Nearly 8,000 children have developed such symptoms, known as multisystem inflammatory syndrome or MIS-C, according to the CDC. At least 66 kids have died from MIS-C.

In July, HHS and the Justice Department said people with long Covid qualify for protection against discrimination under the Americans with Disabilities Act. Medicaid and the Children’s Health Insurance Program must also cover treatments for long Covid, according to the Centers for Medicare and Medicaid Services.

Biden’s 2023 budget would invest $20 million to help deliver better care to long Covid patients, including the development of multispecialty clinics. The budget also includes $25 million to boost CDC research into the risk factors and health effects of long Covid.

Congress has proven less willing than the Biden administration to fund the U.S. Covid response. Senators on Monday reached a $10 billion supplemental Covid funding deal for therapeutics, vaccines and testing — a sum less than half of what the White House wanted.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
World

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing […]

Read More
Consumer sentiment hits record low, inflation fears rise amid Iran war
World

Consumer sentiment hits record low, inflation fears rise amid Iran war

Consumer confidence plunged to a record low in April as fears mounted over rising energy prices and the broader impact of the Iran war, according to a University of Michigan survey Friday. The university’s headline index of consumer sentiment tumbled to 47.6, down 10.7% from the March survey to its lowest on record. Current conditions […]

Read More
Buy this Israeli defense stock because of its ‘battlefield tested tech,’ Bank of America says
World

Buy this Israeli defense stock because of its ‘battlefield tested tech,’ Bank of America says

Elbit Systems has soared 60% so far in 2026, and is set to add further to those gains gains, according to Bank of America. In a research report out Friday, the bank reiterated a buy rating on shares of the Israeli defense company and hiked its 12-month price target to $1,075, implying a nearly 16% […]

Read More